Teva Pharmaceutical Industries Limited shows a strong bullish trend with positive short-term and long-term moving average signals. The stock is currently trading within an upward trend, and recent price action indicates further potential gains. Key support levels are identified around $30.52 and $26.96, with a significant buy signal emerging from a pivot bottom found 21 days ago. The RSI14 at 88 suggests the stock is in overbought territory, increasing the risk, but the overall trend remains bullish. Traders may consider entering a long position with a stop-loss below the $30.08 mark, anticipating a retest of previous highs and potential further upward movement.